MRK · Merck & Co., Inc.

154.53

USD

3.87 (2.57%)

25/08/2026 11:16:22 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$371.70B

14.50

EV/EBITDA

10.2

DIV Yield

3.1%

Payout Ratio

45%

MQV Rating

5Very Weak

As at 25/08/2026 11:16:22 AM

Price Chart

Description

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

All-Companies
All-Consensus
ALL-Recommendations
HALO 200
HALO 500
HALO All
HALO Capital Efficiency
HALO Price Momentum

Key Fundamentals

EPS 3 yr Growth

27.20%

EBITDA Margin

45.20%

Operating Cashflow

$16,472m

Free Cash Flow Return

18.10%

ROIC

20.10%

Interest Coverage

21.60

Quick Ratio

1.30

Performance

52 weeks range

Low 77.58 - 154.49

Trade Value (12mth)

US$315,598,311.00

1 week

9.92%

1 month

14.19%

YTD

39.96%

1 year

73.08%

All time high

153.50

Additional Data

Shares Outstanding (Fully Diluted)

2,470m

HALO Sector

Healthcare

Next Company Report Date

02-Feb-27

Next Ex Dividend Date

15-Sep-26

Next Dividend Pay Date

07-Oct-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
08 August 26EDG
04 August 26EDG
04 August 26EDG
25 June 26EDG
25 June 26EDG

Key Stakeholders

Name	Title
OrbiMed Advisors Private Equity	Subsidiary
Employees Provident Fund	Pension Fund
Robert M. Davis	Individual
Sanat Chattopadhyay	Individual
Richard R. DeLuca	Individual